PE

Peter Emtage

CEO Santa Ana Bio, Inc.

San Francisco Bay Area

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Clinical Development
Biochemistry
Infectious Diseases
Cell Culture
GLP
Drug Discovery
GMP
Clinical Research
FDA
Antibodies
Vaccines
Pharmacology
Biologics
Biotherapeutics
Assay Development
Inflammation
Autoimmunity
Oncology
Biomarker Discovery
Biotechnology

Lists including Peter

AH
AE
AF
AJ

Based in SF

3077 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Santa Ana Bio

Series A

Total Funding: $170M

Work Experience

SA
Santa Ana Bio, Inc

2021

  • Chief Executive Officer

    2021

VV
Versant Ventures

2020

  • Venture Partner

    2020

KP
Kite Pharma

2018 - 2020

  • Global Head of Cell Therapy Research

    2018 - 2020

Cell Design Labs

2016 - 2018

  • Chief Scientific Officer

    2016 - 2018

    Cell Design Labs is a biotherapeutics company pioneering breakthrough science to develop disruptive cell-based therapies for cancer and other devastating diseases. Cell Design Labs leverages the power of the body’s immune system to develop smart, living therapies with the capability to treat our most challenging diseases with unprecedented power, precision, safety and durability.